WBI-1001

DRUG3 trials

Sponsors

Welichem Biotech Inc.

Conditions

Dermatitis, AtopicPsoriasis

Phase 1

Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis

CompletedNCT00837551

Welichem Biotech Inc.Dermatitis, Atopic

Start: 2008-03-31End: 2008-10-31Updated: 2009-02-05

Phase 2

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

CompletedNCT01098734

Welichem Biotech Inc.Dermatitis, Atopic

Start: 2009-11-30End: 2010-11-30Updated: 2011-06-13

A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks

CompletedNCT01098721

Welichem Biotech Inc.Psoriasis

Start: 2010-01-31End: 2010-11-30Updated: 2012-12-20